Peripheral Neuropathy: What It Is, Why Standard Treatments Often Fall Short, and What Actually Helps

Peripheral neuropathy is one of the most misunderstood and undertreated conditions in modern medicine. Patients describe burning feet, electric shocks down the legs, numbness that makes walking feel like stepping on gravel, or fingers that go cold and numb for no apparent reason.

Most are told: "It's nerve damage. Take this medication." The medications — gabapentin, pregabalin, duloxetine — dull the signal. They don't touch the root. And over time, they stop working.

In my 33 years of clinical practice, I have worked with hundreds of peripheral neuropathy patients who came to me after cycling through the standard pathway without resolution. What I see consistently is not that treatment failed — it is that the wrong model was being applied.

This post covers what peripheral neuropathy actually is, why the standard medical approach leaves so many patients stuck, and what a more complete clinical approach looks like.

What Is Peripheral Neuropathy?

The peripheral nervous system consists of every nerve outside the brain and spinal cord: the nerves that carry sensation from your feet to your brain, motor signals from your brain to your muscles, and autonomic signals that control your heart rate, digestion, and circulation.

Peripheral neuropathy means those nerves are damaged, dysfunctional, or chronically inflamed. The result is any combination of:

1. Burning, electric, or stabbing pain (usually in the feet or hands) 2. Numbness or loss of sensation 3. Tingling or pins-and-needles 4. Muscle weakness or balance problems 5. Hypersensitivity to touch (a bedsheet over the feet can feel agonising)

The distribution is usually "stocking and glove" — starting at the extremities and working inward. This reflects the biology: longer nerves are more vulnerable to metabolic stress and inflammation.

The Most Common Causes

Diabetic Neuropathy

The most prevalent form worldwide. Elevated blood sugar damages the tiny blood vessels that supply the nerves, disrupting their oxygen and nutrient supply. What most patients are not told is that this damage is largely reversible in its early stages — and that inflammation, not just glucose, is the key driver.

Idiopathic Neuropathy

"Idiopathic" means we don't know the cause. Approximately 30% of peripheral neuropathy cases carry this label. In my clinical experience, most of these patients have underlying drivers that were never investigated: heavy metal toxicity, B12 and folate depletion, autoimmune activity, thyroid dysfunction, or mitochondrial impairment. The label is a diagnostic endpoint that should be a starting point.

Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Platinum-based chemotherapy drugs are particularly neurotoxic. CIPN can persist for years after treatment ends. Nerve recovery is possible but requires a different approach from standard rehab — one that addresses oxidative stress and supports myelin repair directly.

Autoimmune Neuropathy

Conditions like Guillain-Barré, CIDP, and Sjögren's-related neuropathy involve the immune system attacking peripheral nerve tissue. These require both immune modulation and direct nerve support.

Toxin and Deficiency-Related Neuropathy

Alcohol, heavy metals (lead, mercury, arsenic), and B12 deficiency are all direct neurotoxins. Many patients are depleted in the nutrients their nerves need most — B12, B6, folate, magnesium, and alpha-lipoic acid — and no one has checked.

Why Standard Treatment Often Falls Short

The pharmaceutical approach to peripheral neuropathy treats the symptom — the pain signal — not the nerve itself.

Gabapentinoids (gabapentin, pregabalin) and SNRIs (duloxetine) reduce pain transmission in the central nervous system. For some patients in acute phases, this is appropriate. For patients with chronic neuropathy, these medications do nothing to stop the ongoing nerve damage, address the underlying driver, or support nerve regeneration.

The result is symptom suppression that wears off over time, increasing doses, side effects (cognitive fog, weight gain, dependency), and no change in the underlying trajectory.

Standard physiotherapy, similarly, often applies a musculoskeletal model to a neurological condition. Strengthening exercises and joint mobilisation address the consequences of nerve dysfunction — weakness, balance problems — without addressing the nerve itself.

Neither approach asks: why is this nerve damaged? What would allow it to regenerate?

What Does Support Nerve Regeneration Actually Look Like?

Peripheral nerves can regenerate. The rate is slow — approximately 1mm per day under optimal conditions — but the biology is there. The clinical question is: what creates those optimal conditions?

1. Reduce Neuroinflammation

Chronic peripheral neuropathy is sustained by ongoing inflammation in and around the nerve. This inflammation is driven by oxidative stress, dietary patterns, gut dysbiosis, and unresolved systemic triggers.

The anti-inflammatory interventions with the best evidence base for neuropathy specifically:

Alpha-lipoic acid (ALA) at 600mg daily is the most studied. Multiple meta-analyses show significant reductions in pain, paresthesia, and nerve conduction deficits in diabetic neuropathy, with emerging evidence for other forms. ALA crosses the blood-brain barrier, neutralises free radicals, and improves mitochondrial function in nerve tissue.

Omega-3 fatty acids (EPA and DHA) at 2–3g daily reduce neuroinflammation and have been shown to support axonal regeneration in animal models. Human data is positive but less extensive.

Curcumin with piperine inhibits NF-kB, a key inflammatory pathway implicated in neuropathic pain.

2. Support Myelin Repair

The myelin sheath — the insulating layer around nerve fibres — is the most vulnerable structure in peripheral neuropathy and the one most directly repaired by nutritional support.

Methylcobalamin (active B12) at doses of 1,500–3,000mcg daily (not standard cyanocobalamin) has the strongest evidence for myelin repair. It supports Schwann cell function and has been shown in multiple studies to improve nerve conduction velocity and reduce neuropathic pain. The standard serum B12 test frequently misses functional deficiency — methylmalonic acid and homocysteine are more informative markers.

B complex (specifically B1/thiamine, B6, and folate) is essential for axonal transport and nerve membrane function.

3. Improve Nerve Blood Supply

Nerves require a continuous supply of oxygen and glucose via the vasa nervorum — the tiny blood vessels that run alongside them. In diabetic, vascular, and compression neuropathy, this supply is compromised.

Interventions that improve microvascular function: alpha-lipoic acid, benfotiamine (fat-soluble B1), exercise, and in my clinical practice, Perineural Injection Therapy (PIT) — subcutaneous dextrose injections around the affected nerves that reduce peri-neural inflammation and restore blood flow to the nerve bed.

4. Address the Root Driver

This is the step that is almost always skipped. Without identifying and addressing what caused the neuropathy, all of the above is fighting a losing battle.

Functional Medicine testing that I order for complex neuropathy cases includes:

Organic acids testing — to assess mitochondrial function, B vitamin status, and methylation

Heavy metal testing (DMSA provocation or hair mineral analysis) — particularly in idiopathic cases

Comprehensive metabolic and inflammatory panel — including HbA1c, fasting insulin, CRP, homocysteine, full thyroid panel, and B12/MMA

Stool analysis — gut dysbiosis is a significant but underrecognised driver of systemic inflammation and nutrient malabsorption in neuropathy patients

5. Nerve Mobilisation and Neural Tension Release

Peripheral nerves run through tunnels and channels that can become fibrotic or inflamed, creating mechanical restriction. This is particularly relevant in post-chemotherapy and post-surgical neuropathy.

Specific nerve mobilisation techniques — sometimes called neural flossing or neurodynamic mobilisation — gently move the nerve through its range, reducing adhesions and improving blood flow. These are different from muscle stretching. Performed incorrectly they can aggravate symptoms; performed correctly they are among the most reliably effective interventions I use.

What to Expect in Recovery

Nerve recovery is not linear, and it is not fast. Patients who understand this from the beginning do significantly better — because they do not interpret a bad week as failure.

The general trajectory:

The first 4–6 weeks: reduction in neuroinflammation. Pain quality often changes before intensity decreases — the character shifts from burning to pressure, or from constant to intermittent.

Weeks 6–12: nerve conduction begins to improve. Patients often notice better proprioception, improved balance, and reduced hypersensitivity.

Months 3–6+: myelin repair and axonal regeneration progress. Sensation begins to return in areas that were numb.

The pace depends on the severity and duration of the neuropathy, the degree of axonal damage versus demyelination (demyelination is faster to repair), and how consistently the root drivers are addressed.

When to Seek Specialist Assessment

If you are managing peripheral neuropathy and any of the following apply, a more thorough evaluation is warranted:

1. The diagnosis is idiopathic — no cause has been identified 2. You have tried standard medications without adequate relief 3. Your neuropathy is worsening despite treatment 4. You have not had comprehensive metabolic and nutritional testing 5. Your provider has not discussed nerve regeneration, only symptom management

Peripheral neuropathy is a condition where a more complete clinical picture — integrating functional medicine, targeted nutrition, specific manual therapy, and a genuine investigation of root cause — produces outcomes that the standard pathway cannot.

A Note on the Nervous System as a Whole

One dimension of peripheral neuropathy that is consistently underaddressed is the role of the central nervous system in maintaining the pain state.

When the peripheral nerves have been inflamed and painful for months or years, the central nervous system undergoes changes — increased sensitisation, lowered pain thresholds, amplified processing of nerve signals. This is why neuropathic pain often persists even after the peripheral driver has improved.

Addressing central sensitisation — through nervous system regulation practices, sleep restoration, stress reduction, and specific down-regulation techniques — is not a secondary consideration. It is part of the same clinical picture.

This is why the programs I work with combine targeted nutrition and nerve support with nervous system regulation from the beginning. The peripheral and central components need to be addressed together.

Where to Start

If you are managing peripheral neuropathy and have not found adequate answers through the standard pathway, the next step is a comprehensive assessment.

Take the free Nerve Pain Assessment to identify the pattern of your nerve pain and get a personalised starting point.

For those in Squamish, BC — an in-person session gives me the opportunity to do a full neuromuscular assessment, identify nerve tension and restriction patterns, and map a clear clinical direction.

For international clients, the 12-Week Nerve Pain Freedom Program takes the same integrated approach — delivered online with weekly curriculum, Functional Medicine guidance, and direct access to my clinical protocols.

Peripheral neuropathy responds. The key is working with the biology instead of around it.

---

Mina Kavia is a Registered Physiotherapist and Registered Acupuncturist with 33 years of clinical experience, specialising in complex nerve pain and peripheral neuropathy at Physio Squamish and online via nervecoachmina.com.